Pierre Perrin-Monlouis Dernière mise à jour: 20 octobre 2021
Oracle and PPD Build on Long-Standing Relationship to Deliver Faster, Easier-to-Use Application at Clinical Trial Investigative Sites
DIA 44TH ANNUAL MEETING, BOSTON 24-JUN-2008 05:00 AM
Today, Oracle and PPD, Inc. (Nasdaq: PPDI), a leading global contract research organization (CRO), announced that PPD has implemented Oracle(r) Remote Data Capture (RDC) Onsite 4.5.3, the newest version of Oracle’s electronic data capture (EDC) solution, across eight active studies and 600 global investigative sites.
PPD integrated Oracle RDC Onsite 4.5.3 into its suite of clinical trial management applications this past March to accelerate entry and management of clinical trial data and to expand real-time reporting capabilities for its pharmaceutical, biotechnology and medical device clients.
Oracle RDC Onsite 4.5.3 has proven easier and faster to use with electronic case report form (eCRF) pages opening in two to three seconds. In addition, Oracle RDC Onsite 4.5.3 requires fewer key strokes to navigate pages, displays all information on a single CRF screen and allows investigators to open multiple pages simultaneously.
Users can also leverage the system’s integrated discrepancy management capabilities to accelerate data corrections across the system.
PPD is leveraging the enhanced product’s zero footprint to streamline system and site set-up and management. Oracle RDC Onsite 4.5.3, which is accessed via a Web browser and standard Internet connection, does not require investigational sites to load or maintain additional software, reducing information technology management complexity. The system also includes 128-bit encryption to keep data secure.
PPD, as part of a group of customer advisors, worked closely with Oracle to develop new functionality for Oracle RDC Onsite 4.5.3, focusing particularly on increasing investigator site performance, simplifying the user interface and eliminating site software installation through a fully Web-based EDC system.
PPD has integrated its interactive voice response (IVR) system with the Oracle Clinical platform. Investigators can now enroll and/or randomize patients with the IVR, automatically transmitting enrollment data into the Oracle Clinical and Oracle Remote Data Capture Onsite system, all during the same phone call.
Oracle RDC Onsite 4.5.3 helps life sciences organizations and CROs conduct clinical trials and studies more effectively and efficiently. Fully integrated with Oracle Clinical, Oracle Remote Data Capture Onsite 4.5.3 features an enhanced user interface and expanded reporting capabilities.
PPD has worked with Oracle since 2000 to develop Oracle Clinical solutions.
“Extensive collaboration between Oracle and PPD has resulted in a greatly enhanced version of Oracle Remote Data Capture Onsite that focuses on ease of use for trial investigators and improved manageability of the system,” said Susan Atkinson, senior vice president of global biostatistics and data management at PPD. “We, along with our industry colleagues, worked with Oracle throughout the development process, which included extensive field testing. Our project managers and site investigators have reported a marked improvement in usability and navigation speed with Oracle Remote Data Capture 4.5.3, which is resulting in faster, more accurate data entry, thus accelerating the clinical trial process for our clients.”
Oracle Remote Data Capture 4.5.3 Press Release
Oracle Remote Data Capture 4.5.3 Data Sheet
Oracle in Health Sciences
PPD is a leading global contract research organization providing discovery, development and post-approval services as well as compound partnering programs. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 31 countries and more than 10,400 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help its clients and partners maximize returns on their R&D investments and accelerate the delivery of safe and effective therapeutics to patients. For more information, visit our Web site at http://www.ppdi.com.
Oracle (NASDAQ: ORCL) is the world’s largest enterprise software company. For more information about Oracle, please visit our Web site at http://www.oracle.com.
# # #
Oracle is a registered trademark of Oracle Corporation and/or its affiliates. Other names may be trademarks of their respective owners.